IDEX Reports Third Quarter Results and Raises Full Year Guidance

Third Quarter 2023 Highlights






Sales of $793.4 million, down 4% overall and 6% organically



Reported diluted EPS of $2.75, up 17%, and adjusted diluted EPS of $2.12, down 1%, included a lower...

Related Keywords

United States ,America ,Eric Ashleman ,Ericd Ashleman ,Allison Lausas ,Health Science Technologies ,New York Stock Exchange ,Micropump Inc ,Health Science ,Muon Group ,Corporate Office ,York Stock Exchange ,Exchange Commission ,Chief Executive Officer ,Months Ended September ,Diluted Earnings ,Share Attributable ,Net Income ,Adjusted Diluted ,Metering Technologies ,Science Technologies ,Diversified Products ,Executive Officer ,President Eric Ashleman ,Interim Chief Financial Officer ,Chief Accounting Officer Allison Lausas ,Private Securities Litigation Reform Act ,Hurst Jaws ,Consolidated Statements ,Common Share ,Cash Flows ,Segment Financial Information ,Iridian Spectral Technologies ,Pipeline Renewal Technologies ,Consolidated Adjusted ,Net Sales ,Organic Net ,Reported To Adjusted Gross Profit ,Gross Margin ,Reported To Adjusted Net Income Attributable ,Adjusted Net Sales ,Operating Activities ,Free Cash Flow ,Markets ,